Jeremy Richter, MD
Orthopaedic Surgery · Dublin, GANPI 1083833321
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $730 of the $891 with a category attached, or 81.9%. 20 manufacturers reported payments, led by Arthrex at 31.8% of the total. That places this record below the midpoint for orthopaedic surgery clinicians in GA, where the typical reported total is $3,375.
Across 40 payments — averaging $22.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$284
- Pacira Therapeutics, Inc.$129
- ERMI LLC$66
- Boston Scientific$39
- Endo Pharmaceuticals Inc.$39
- Smith+Nephew$36
- plus $297 from 14 others
What the payments were for
- Travel & lodging$16118%
- Food & beverage$73082%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $284 |
| Pacira Therapeutics, Inc. | 7 | $129 |
| ERMI LLC | 3 | $66 |
| Boston Scientific | 3 | $39 |
| Endo Pharmaceuticals Inc. | 2 | $39 |
| Smith+Nephew | 2 | $36 |
| Davol Inc. | 1 | $33 |
| Zimmer Biomet | 2 | $30 |
| Johnson & Johnson | 2 | $28 |
| Ferring Pharmaceuticals Inc. | 2 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Kerecis Limited | 2 | $24 |
| Biocomposites Inc | 1 | $24 |
| United Orthopedics LLC | 1 | $23 |
| Solventum Corporation | 1 | $20 |
| Vericel Corporation | 1 | $16 |
| Stryker | 1 | $16 |
| Dynasplint Systems Inc. | 1 | $14 |
| Globus Medical | 1 | $13 |
| Orthofix Medical, Inc. | 1 | $5 |
How this compares
$891 in reported general payments places this provider in the 25th percentile of 654 orthopaedic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 111 | $810 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $462 |
| Pregabalin | 11 | $267 |
| Promethazine Hcl | 36 | $198 |
| Ibuprofen | 13 | $136 |
| Tramadol Hcl | 20 | $88 |
| Meloxicam | 19 | $86 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Dublin
- Charles DecookCumming$48.3M
- Ormonde MahoneyAthens$10.6M
- Daxes BanitWarner Robins$5.5M
- John DorchakColumbus$3.8M
- Daniel SilcoxAtlanta$3.4M
- Dennis DevitoAtlanta$1.5M
- Jon MinterAlpharetta$1.2M
- George GuildCumming$987K
- William TallyAthens$870K
- Julian PriceAthens$805K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.